OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
APG58

Axon Partners Group SA

Investment Management & Fund OperatorsVerified

Axon Partners Group has a fully diluted share count of 5,195,913, with no additional shares outstanding in the diluted calculation, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents, which limits the ability to evaluate short-term financial flexibility. Profitability metrics are not available in the valuation snapshot, but the company reported an actual EPS of 1.02 EUR against a mean estimate of 1.24 EUR, suggesting earnings performance has fallen short of analyst expectations. Revenue of 22.62 million EUR also lagged the mean estimate of 27.4 million EUR, indicating potential challenges in meeting growth targets. Segment and geographic exposure data are not disclosed in the available financials, which limits the ability to assess revenue concentration or regional risk. The company does not provide segment-level breakdowns in its latest filings, making it difficult to evaluate the contribution of different business lines or geographic regions. Looking ahead, the company is expected to report EBIT of 8.9 million EUR, according to analyst estimates, but no specific growth trajectory is provided in the outlook. The absence of historical revenue growth data and forward-looking guidance makes it difficult to assess the company's long-term growth potential. Risk factors include the inability to assess liquidity risk and the lack of detailed disclosures on capital structure. The dilution risk is currently low, as no additional shares are outstanding in the diluted calculation, but the absence of capital structure details limits the ability to evaluate future dilution potential. Recent events include the publication of earnings and revenue figures that fell below analyst estimates, but no material filings or transcripts have been disclosed in the available data. The company has not issued any recent press releases or investor updates that would provide additional context on its strategic direction.

30-day price · APG+0.15 (+0.4%)
Low$38.52High$51.11Close$42.02As of18 May, 00:00 UTC
Profile
CompanyAxon Partners Group SA
TickerAPG.MC
SectorFinancials
BusinessBanking & Investment Services
Industry groupBanking & Investment Services
IndustryInvestment Management & Fund Operators
AI analysis

Business. Axon Partners Group SA provides investment management and fund operating services to institutional and private clients, generating revenue primarily through management fees and performance-based incentives.

Classification. Axon Partners Group is classified under the Capital Markets industry and Investment Management & Fund Operators sector, with a confidence level of 0.92 based on verified market data.

Axon Partners Group has a fully diluted share count of 5,195,913, with no additional shares outstanding in the diluted calculation, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents, which limits the ability to evaluate short-term financial flexibility. Profitability metrics are not available in the valuation snapshot, but the company reported an actual EPS of 1.02 EUR against a mean estimate of 1.24 EUR, suggesting earnings performance has fallen short of analyst expectations. Revenue of 22.62 million EUR also lagged the mean estimate of 27.4 million EUR, indicating potential challenges in meeting growth targets. Segment and geographic exposure data are not disclosed in the available financials, which limits the ability to assess revenue concentration or regional risk. The company does not provide segment-level breakdowns in its latest filings, making it difficult to evaluate the contribution of different business lines or geographic regions. Looking ahead, the company is expected to report EBIT of 8.9 million EUR, according to analyst estimates, but no specific growth trajectory is provided in the outlook. The absence of historical revenue growth data and forward-looking guidance makes it difficult to assess the company's long-term growth potential. Risk factors include the inability to assess liquidity risk and the lack of detailed disclosures on capital structure. The dilution risk is currently low, as no additional shares are outstanding in the diluted calculation, but the absence of capital structure details limits the ability to evaluate future dilution potential. Recent events include the publication of earnings and revenue figures that fell below analyst estimates, but no material filings or transcripts have been disclosed in the available data. The company has not issued any recent press releases or investor updates that would provide additional context on its strategic direction.
Key takeaways
  • Axon Partners Group's earnings and revenue performance has underperformed analyst estimates.
  • The company has no dilution from stock options or convertible securities, as shares outstanding are the same in basic and diluted calculations.
  • Liquidity risk could not be assessed due to missing balance-sheet data and lack of going-concern language.
  • No segment or geographic revenue breakdown is available, limiting visibility into business diversification.
  • Analysts expect EBIT of 8.9 million EUR, but no detailed growth trajectory is provided.
  • --
  • ## RATIONALES
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyEUR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$9.4M$1.8M$1.6M$630.2k
FY-3$13.5M$3.5M$3.3M$2.5M
FY-2$17.7M$5.1M$4.6M$4.4M
FY-1$19.9M$5.6M$4.1M$4.2M
FY0$22.6M$6.5M$5.3M$5.6M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$18.0M$10.3M$3.4M
FY-3$24.9M$14.4M$6.3M
FY-2$24.3M$16.9M$9.6M
FY-1$30.1M$20.4M
FY0$33.6M$24.5M
PeriodOCFCapExFCFSBC
FY-4$4.1M-$596.7k$630.2k
FY-3$2.6M-$276.1k$2.5M
FY-2$1.7M$0.00$4.4M
FY-1$4.6M-$60.8k$4.2M
FY0$7.2M-$21.4k$5.6M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Banking & Investment Services · cohort 589 companies
MetricAPGActivity
Op margin25.7% medp25 3.6% · p75 52.2%
Net margin21.2% medp25 4.2% · p75 45.9%
Gross margin81.4% medp25 46.5% · p75 95.8%
CapEx / revenue-1.7% medp25 -4.8% · p75 -0.4%
Debt / equity14.8% medp25 0.1% · p75 134.4%
Observations
IR observations
Mean EPS estimate1.24 EUR
Last actual EPS1.02 EUR
Mean revenue estimate27,400,000 EUR
Last actual revenue22,620,000 EUR
Mean EBIT estimate8,900,000 EUR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-10 09:54 UTC#d407d258
Market quoteclose EUR 16.90 · shares 0.01B diluted
no public URL
2026-05-10 09:54 UTC#2afa25d6
Source: analysis-pipeline (hybrid)Generated: 2026-05-27 09:07 UTCJob: bc30a255